HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Study on type I and type III procollagen mRNA and in situ collagen proteins expressions in hypertrophic scars after intralesional Kenalog treatment].

AbstractOBJECTIVE:
This is to investigate the mechanism of effects of Kenalog on type I and III collagen syntheses and degradation in hypertrophic scars.
METHODS:
Intralesional injection of Kenalog was performed on 6 patients with hypertrophic scars. On the 3rd day and 7th day after the treatment, 6 samples from the 6 patients each were collected and type I and III collagen proteins and in situ procollagen mRNA expressions were studied by means of immunohistochemistry and molecular biology.
RESULTS:
On the 7th day after intralesional injection of Kenalog, type I collagen proteins reduced (P < 0.05) and type III collagen proteins did not reduced significantly (P > 0.05). On the 3rd day after intralesional injection of Kenalog, both type I and type III procollagen mRNA expressions were significantly inhibited and on the 7th day both procollagen mRNA expressions decreased further.
CONCLUSIONS:
Intralesional Kenalog may inhibit type I procollagen mRNA expression more than type III. Gene expressive intensions of type I and III procollagen were higher in hypertrophic scars than in normal skin.
AuthorsS Xu, B Guan, W Bao
JournalZhonghua zheng xing wai ke za zhi = Zhonghua zhengxing waike zazhi = Chinese journal of plastic surgery (Zhonghua Zheng Xing Wai Ke Za Zhi) Vol. 16 Issue 4 Pg. 236-8 (Jul 2000) ISSN: 1009-4598 [Print] China
PMID11593681 (Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Procollagen
  • RNA, Messenger
  • Collagen
  • Triamcinolone Acetonide
Topics
  • Adolescent
  • Adult
  • Burns (complications)
  • Child
  • Cicatrix, Hypertrophic (drug therapy, genetics, metabolism)
  • Collagen (biosynthesis, genetics)
  • Female
  • Humans
  • In Situ Hybridization
  • Male
  • Middle Aged
  • Procollagen (biosynthesis, genetics)
  • RNA, Messenger (biosynthesis, genetics)
  • Triamcinolone Acetonide (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: